Sotigalimab

Sotigalimab Chemische Eigenschaften,Einsatz,Produktion Methoden

Pharmakologie

Sotigalimab binds to CD40 on a variety of immune cell types. This triggers the cellular proliferation and activation of antigen-presenting cells (APCs), and activates B cells, and effector and memory T cells. This results in an enhanced immune response against tumor cells. Sotigalimab also binds to and activates CD40 present on the surfaces of some solid tumor cells, leading to apoptosis and decreased tumor growth.

Sotigalimab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Sotigalimab Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Aladdin Scientific		tp@aladdinsci.com	United States	57505	58
Shanghai YuanYe Biotechnology Co., Ltd.	021-61312847; 18021002903	3008007409@qq.com	China	71826	60
ShangHai Biochempartner Co.,Ltd	177-54423994 17754423994	2853530910@QQ.com	China	8000	62
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1566	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10308	58
TargetMol Chemicals Inc.	4008200310	marketing@tsbiochem.com	China	24961	58
Biolab Reagents	027-65279366 18108604356	products@biolabreagent.com	China	9868	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 086-15871494362 13720134139	orders@jknbiochem.com	China	6762	58
Shanghai Aladdin Biochemical Technology Co.,Ltd.	400-6206333 13167063860	anhua.mao@aladdin-e.com	China	48457	58
Changsha Fuzhen Biotechnology Co.，LTD	0731-13823398 15111215862	313359644@qq.com	China	4161	58

---

• Sotigalimab
• Research Grade Sotigalimab(DHD68911)
• Sotigalimab (anti-CD40)
• Research Grade Sotigalimab
• 2305607-45-6